Get the Stockscreener App
48.46
6.62%
3.01
After Hours:
48.46
Omnicell Inc stock is traded at $48.46, with a volume of 673.11K.
It is up +6.62% in the last 24 hours and up +22.68% over the past month.
Omnicell Inc provides automation and business analytics software for healthcare providers. It helps its customers to define and deliver cost-effective medication management that is designed to equip and empower pharmacists and nurses to focus on patient care rather than administrative tasks, and to drive improved clinical, operational, and financial outcomes across all care settings. Omnicell generates the vast majority of its revenue in the United States.
See More
Previous Close:
$45.45
Open:
$45.69
24h Volume:
673.11K
Relative Volume:
1.25
Market Cap:
$2.11B
Revenue:
$1.08B
Net Income/Loss:
$-20.76M
P/E Ratio:
-62.94
EPS:
-0.77
Net Cash Flow:
$151.63M
1W Performance:
+15.88%
1M Performance:
+22.68%
6M Performance:
+48.51%
1Y Performance:
+40.42%
1-Day Range:
$44.87
$48.60
1-Week Range:
$42.08
$48.60
52-Week Range:
$25.12
$55.74
Omnicell Inc Stock (OMCL) Company Profile
Name
Omnicell Inc
Sector
Industry
Phone
(877) 415-9990
Address
4220 NORTH FREEWAY, FORT WORTH
Compare OMCL with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
OMCL
Omnicell Inc
|
48.46 | 2.11B | 1.08B | -20.76M | 151.63M | -0.77 |
|
VEEV
Veeva Systems Inc
|
226.76 | 36.93B | 2.57B | 615.26M | 996.76M | 3.32 |
|
SOLV
Solventum Corp
|
72.48 | 12.43B | 8.26B | 66.00M | 1.17B | 0.00 |
|
TEM
Tempus Ai Inc
|
62.98 | 10.01B | 640.44M | -743.28M | -206.93M | 0.00 |
|
DOCS
Doximity Inc
|
53.39 | 9.94B | 493.63M | 160.55M | 162.20M | 0.55 |
|
HQY
Healthequity Inc
|
102.47 | 8.91B | 1.10B | 105.67M | -197.98M | 0.1475 |
Omnicell Inc Stock (OMCL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-31-24 | Downgrade | BofA Securities | Buy → Neutral |
| Aug-02-24 | Upgrade | Barclays | Underweight → Equal Weight |
| Jan-03-24 | Initiated | Barclays | Underweight |
| Nov-03-23 | Downgrade | BTIG Research | Buy → Neutral |
| Nov-03-23 | Upgrade | Piper Sandler | Neutral → Overweight |
| Nov-03-23 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Oct-11-23 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Sep-26-23 | Reiterated | Wells Fargo | Underweight |
| Aug-02-23 | Downgrade | Piper Sandler | Overweight → Neutral |
| Jul-20-23 | Downgrade | Wells Fargo | Overweight → Underweight |
| Feb-27-23 | Upgrade | The Benchmark Company | Hold → Buy |
| Nov-03-22 | Downgrade | The Benchmark Company | Buy → Hold |
| Sep-16-22 | Initiated | KeyBanc Capital Markets | Overweight |
| Sep-09-22 | Initiated | BofA Securities | Buy |
| Jul-15-22 | Initiated | SVB Leerink | Mkt Perform |
| Dec-06-21 | Resumed | Wells Fargo | Overweight |
| Jun-09-21 | Initiated | JP Morgan | Neutral |
| May-24-21 | Initiated | BTIG Research | Buy |
| Feb-02-21 | Upgrade | Piper Sandler | Neutral → Overweight |
| Dec-08-20 | Initiated | Berenberg | Buy |
| Dec-03-20 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Jul-07-20 | Initiated | Stephens | Overweight |
| Feb-07-20 | Reiterated | Dougherty & Company | Buy |
| Nov-21-19 | Reiterated | Dougherty & Company | Buy |
| Jul-26-19 | Upgrade | Craig Hallum | Hold → Buy |
| Mar-07-19 | Reiterated | Dougherty & Company | Buy |
| Jun-29-18 | Resumed | The Benchmark Company | Buy |
| Sep-05-17 | Reiterated | The Benchmark Company | Buy |
| Jul-28-17 | Reiterated | Dougherty & Company | Buy |
| Apr-21-17 | Downgrade | Piper Jaffray | Overweight → Neutral |
| Jan-19-17 | Initiated | Dougherty & Company | Buy |
| Dec-06-16 | Reiterated | The Benchmark Company | Buy |
| Jul-07-16 | Reiterated | FBR Capital | Outperform |
| Mar-21-16 | Reiterated | Topeka Capital Markets | Buy |
| Jan-07-16 | Initiated | The Benchmark Company | Buy |
| Nov-16-15 | Reiterated | Topeka Capital Markets | Buy |
| Oct-30-15 | Reiterated | FBR Capital | Outperform |
| Sep-28-15 | Upgrade | Sidoti | Neutral → Buy |
| Jul-31-15 | Reiterated | Topeka Capital Markets | Buy |
View All
Omnicell Inc Stock (OMCL) Latest News
Little Excitement Around Omnicell, Inc.'s (NASDAQ:OMCL) Revenues - Simply Wall St
Millrace Asset Group Inc. Invests $1.22 Million in Omnicell, Inc. (NASDAQ:OMCL) - MarketBeat
Advantage Alpha Capital Partners LP Sells 24,485 Shares of Omnicell, Inc. (NASDAQ:OMCL) - MarketBeat
Central Fill Pharmacy Automation Market Future Business - openPR
Omnicell's SWOT analysis: healthcare tech stock navigates market shifts - Investing.com
Global Surgery Management Software Market Size, Share - openPR
Omnicell's SWOT analysis: healthcare tech stock navigates market shifts By Investing.com - Investing.com UK
Pharmacy Automation System Market to Hit $11.21 Billion by 2030 | Becton, Dickinson and Company, Omnicell, - EIN News
Omnicell to Present at the Piper Sandler 36th Annual Healthcare Conference - Business Wire
Pacer Advisors Inc. Has $54.35 Million Stake in Omnicell, Inc. (NASDAQ:OMCL) - MarketBeat
Connor Clark & Lunn Investment Management Ltd. Buys 259,463 Shares of Omnicell, Inc. (NASDAQ:OMCL) - MarketBeat
OMCL (Omnicell) Cash From Other Investing Activities : $0 Mil (TTM As of Sep. 2024) - GuruFocus.com
OMCL (Omnicell) Cyclically Adjusted PS Ratio : 1.74 (As of Nov. 21, 2024) - GuruFocus.com
Beyond The Numbers: 6 Analysts Discuss Omnicell Stock - Benzinga
Wall Street Analysts Believe Omnicell (OMCL) Could Rally 26.73%: Here's is How to Trade - Yahoo Finance
Brown Capital Management LLC Reduces Stock Position in Omnicell, Inc. (NASDAQ:OMCL) - MarketBeat
Here's Why You Should Add OMCL Stock to Your Portfolio Now - MSN
Royce & Associates LP Purchases New Holdings in Omnicell, Inc. (NASDAQ:OMCL) - MarketBeat
JPMorgan raises Omnicell target to $44, maintains neutral stance By Investing.com - Investing.com Canada
Omnicell prices $150M debt offering via issuance of convertible senior notes - MSN
Robotic Dentistry Market: Trade Analysis and Growth - openPR
Omnicell Announces Pricing of $150 Million Convertible Senior Notes Offering - Business Wire
Omnicell (NASDAQ:OMCL) Shares Gap DownHere's What Happened - MarketBeat
The Top 100 Healthcare Technology Companies of 2024 - The Healthcare Technology Report.
Medication Management Systems Market Will Accelerate Rapidly - openPR
Principal Financial Group Inc. Sells 31,062 Shares of Omnicell, Inc. (NASDAQ:OMCL) - MarketBeat
Omnicell Announces Proposed Private Placement of $150 Million of Convertible Senior Notes - BioSpace
Omnicell announces $150 million convertible notes offering - Investing.com
What is Zacks Research's Estimate for Omnicell Q1 Earnings? - MarketBeat
Sumitomo Mitsui Trust Group Inc. Acquires New Shares in Omnicell, Inc. (NASDAQ:OMCL) - MarketBeat
Omnicell (NASDAQ:OMCL) Downgraded to "Hold" Rating by StockNews.com - MarketBeat
Victory Capital Management Inc. Raises Stake in Omnicell, Inc. (NASDAQ:OMCL) - MarketBeat
Better Than Expected Q2 Earnings Prompt Buying Interest In Omnicell - RTTNews
Omnicell, Inc. (NASDAQ:OMCL) Given Average Rating of "Hold" by Analysts - MarketBeat
Omnicell Inc. (OMCL) Quarterly 10-Q Report - Quartzy
New Horizons in Medication Management Tools Market Exploring - openPR
Surging Earnings Estimates Signal Upside for Omnicell (OMCL) Stock - MSN
Omnicell, Inc. (NASDAQ:OMCL) Q3 2024 Earnings Call Transcript - MSN
Omnicell's SWOT analysis: healthcare tech firm's stock rides upgrade wave By Investing.com - Investing.com Australia
Omnicell's SWOT analysis: healthcare tech firm's stock rides upgrade wave - Investing.com India
Apple Satellite Connectivity Provider Globalstar And Timberland Parent V.F Corp Are Among Top 7 Mid Cap Gainers Last Week (Oct 28-Nov 1): Are The Others In Your Portfolio? - Benzinga
Omnicell Third Quarter 2024 Earnings: EPS Beats Expectations - Yahoo Finance
Omnicell, Inc. Just Beat EPS By 43%: Here's What Analysts Think Will Happen Next - Simply Wall St
OMCL Stock Soars on Q3 Earnings & Revenue Beat, '24 EPS View Raised - MSN
Omnicell, Inc. (OMCL) Soars to 52-Week High, Time to Cash Out? - MSN
Rice Hall James & Associates LLC Invests $2.72 Million in Omnicell, Inc. (NASDAQ:OMCL) - MarketBeat
Omnicell Appoints Nnamdi Njoku as Executive Vice President and C - GuruFocus.com
Omnicell cut to neutral by BofA, lack of visibility into growth cited - MSN
Omnicell Q3 Earnings: Look At The Growth Segment (NASDAQ:OMCL) - Seeking Alpha
A Look At The Fair Value Of Omnicell, Inc. (NASDAQ:OMCL) - Yahoo Finance
Omnicell Inc Stock (OMCL) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.88%
1.35%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):